≥98% HPLC PURITY

CJC-1295

5mg / 10 VIALS

MINDTEK · RESEARCH USE ONLY

RESEARCH USE ONLY COA VERIFIED SOLUTION PHASE

CJC-1295

CJC-1295 (without DAC)

GHRH analogue. Stimulates endogenous GH pulses via pituitary GHRH-R binding. Research half-life: ~30 min without DAC.

MW: 3367.9 Da CAS: 863288-34-0 Per Vial: 5mg Kit: 10 Vials

SELECT QUANTITY

1 Vial $60Order

3 Vials Save 25%$50 eaOrder

5 Vials Save 18%$45 eaOrder

10 Vials Best Value$45 eaOrder

Mechanism of Action

CJC-1295 (mod GRF 1-29) binds pituitary GHRH receptors to amplify GH pulse amplitude and frequency. Without DAC, bioavailable half-life approximates 30 min, preserving natural pulsatile GH secretion patterns studied in anti-ageing and body composition research.

⚡

Pituitary GHRH-R Binding

Primary receptor engagement pathway confirmed in vitro and in vivo.

🔬

GH Pulse Amplification

Downstream signalling cascade activating repair and regenerative gene expression.

🧬

IGF-1 Downstream Signalling

Tertiary effect pathway documented across multiple independent research groups.

Research Evidence

DATA = directly reported in cited study · INFERENCE = derived · SPECULATION = hypothesis

Ionescu M & Frohman LA (2006) J Clin Endocrinol Metab 91(3)DATA

Modified GHRH 1-29 demonstrated consistent GH/IGF-1 elevation without desensitisation in healthy adults over 28-day study (DATA).

Walker RF (2006) Rejuvenation Res 9(1)DATA

CJC-1295 achieved plasma GH levels 2–10× baseline with single injection; IGF-1 elevated for 6+ days in adult subjects (DATA).

Teichman SL et al. (2006) J Clin Endocrinol Metab 91(3)DATA

Safety and pharmacokinetics of CJC-1295: no serious adverse events; dose-dependent GH and IGF-1 increases documented (DATA).

Certificate of Analysis

Every Mindtek batch is independently tested before release. We were among the first peptide suppliers in Southeast Asia to implement mandatory third-party HPLC verification — a standard, not an exception.

HPLC Purity≥98.0%

Bacterial Endotoxins≤5 EU/mg

Water Content (Karl Fischer)≤8.0%

Peptide Content≥80%

StandardUSP/EP

Request CoA for This Batch →

Research Protocol Reference

For laboratory research use only — not for human or veterinary use.

💧

Reconstitution

Add sterile bacteriostatic water (0.9% benzyl alcohol) slowly against the vial wall. Gently swirl — do not vortex. Allow 5 min for complete dissolution.

🧊

Storage

Store solution-phase at -20°C. Post-reconstitution: maintain at 2–8°C, use within 28 days. Protect from light. Avoid repeated freeze-thaw cycles.

📐

Administration

SubQ or IM administration in standard research protocols. Insulin syringe recommended for precise dosing. Refer to published literature for compound-specific protocols.

Frequently Asked Questions

What is CJC-1295 without DAC?

CJC-1295 (mod GRF 1-29) is a modified GHRH analogue with ~30-min half-life. Preserves natural pulsatile GH secretion patterns vs. DAC version. Research use only.

Difference between CJC-1295 with and without DAC?

DAC extends half-life to 8+ days via albumin binding. Without DAC: ~30-min activity, better simulating natural GHRH pulsatility in research models.

Can CJC-1295 be combined with Ipamorelin?

CJC-1295 and Ipamorelin target complementary pathways (GHRH-R vs. ghrelin/GHS-R). Both available from Mindtek.

Ready to Order CJC-1295?

Mindtek ships solution-phase, independently verified research compounds to qualified researchers globally. First in Southeast Asia.

Place an Order Research Hub